Encompass Health Corp (EHC) Stock AnalysisEHCEncompass Health Corp

Encompass Health Corporation is a provider of inpatient rehabilitation services. The Company provides specialized rehabilitative treatment, using technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability. It operates hospitals in approximately 39 states and Puerto Rico, with concentrations in Florida and Texas. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver patient care services. It offers neurological, spinal & brain-related rehabilitation, which include brain injury rehabilitation, multiple trauma rehabilitation, neurological rehabilitation, spasticity management, spinal cord injury rehabilitation and stroke rehabilitation. It also offers orthopedic & joint-related rehabilitation, which includes amputee rehabilitation, chronic condition management, hip rehabilitation and orthopedic rehabilitation. It operates in the Healthcare sector (SERVICES-HOSPITALS industry).

Encompass Health Corp is a good buy right now, trading at $123.33 with a forward P/E of 18.90, which is attractive compared to the industry average of 25.5. The stock has shown a year-to-date change of +15.94%, indicating strong momentum. Additionally, the company is set to benefit from a 2.3% increase in Medicare payments, which will positively impact its financial results. The main risk is the insider selling activity, with executives selling shares at an average price of $125.95, which could signal caution among some investors.